Ledger.Open graph →
SEC Form D · Amendment · filed January 12, 2021

Elucida Oncology, Inc

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Monmouth Junction, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Geno Germano · Monmouth Junction, NJExec · DirectorUlrich Wiesner · Monmouth Junction, NJDirectorTeresa Ressel · Monmouth Junction, NJDirectorRobert Ruffolo · Monmouth Junction, NJDirectorRobert Essner · Monmouth Junction, NJExec · DirectorEliel Bayever · Monmouth Junction, NJExecMichael Smith · Monmouth Junction, NJDirectorKai Ma · Monmouth Junction, NJExecGregory Adams · Monmouth Junction, NJExecTim Boris · Monmouth Junction, NJDirectorJohn M. Courtright · Elmhurst, ILDirectorRalph Yarro · Orem, UTDirectorAyman M. Shahin · Dubai, C0DirectorMichael Wolfgramm · Orem, UTExec · DirectorJakub Rehor · Reno, NVExecSpencer Patterson · Orem, UTExec · DirectorJonathan R. Simon · New York, NYDirectorJosh Froelich · Houston, TXExecKasper Bihlet · Houston, TXExecJan F. Van Eck · New York, NYDirectorDavid Anthony · Broomfield, CODirectorJanice Craig · Vancouver, British Columbia, CanadaDirectorDion F. Chu · New York, NYExec · DirectorMichael F. Peng · New York, NYDirectorHelene Servillon · Dover, DEExec · DirectorKara Forney · Albuquerque, NMDirectorDane F. Lund · New York, NYDirectorVictor D. Woolridge · New York, NYExecJonathan Lamm · New York, NYExecMelissa Weiler · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗